Biotechnology
Sort by: Featured Most recent Most read Most commented
62 results total, viewing 41 - 50
EDC approves Alexion tax cut
The R.I. Economic Development Corporation approved a corporate tax cut Monday night for Alexion Pharmaceuticals under the state’s Jobs Development Act. more
R.I. companies honored at Museum of Science’s ‘Invented Here’ awards
IlluminOss Medical Inc. and G-Form LLC were two of the four companies honored at the Boston Museum of Science’s second annual “Invented Here” awards. more
| 10/15/12
NIH awarded $147M to R.I. in FY2012
During the fiscal year ended June 30, the National Institutes of Health awarded a total of $146.96 million in grants to Rhode Island hospitals, universities and companies. more
Norman Prince Neurosciences Institute lands $600K for brain research, lecture series
The Norman Prince Neurosciences Institute at Rhode Island Hospital was awarded three philanthropic gifts totaling nearly $600,000 to improve brain science in the state of Rhode Island by supporting research and establishing a lecture series. more
Covidien’s Mallinckrodt completes CNS Therapeutics acquisition
Medical device maker Covidien PLC’s pharmaceutical arm, Mallinckrodt, has completed its acquisition of St. Paul, Minn.-based CNS Therapeutics Inc. for roughly $100 million. more
| 10/3/12
IlluminOss lands $28M in Series C financing round
East Providence-based medical device firm IlluminOss Medical Inc. - founded by Robert A. Rabiner in 2007 - has raised $28 million in a Series C financing round that included the Slater Technology Fund. more
URI chemist awarded $400K ‘early career’ grant by NSF
Jason Dwyer, an assistant chemistry professor at the University of Rhode Island, has been awarded a five-year, $400,000 research grant from the National Science Foundation. more
Covidien’s Mallinckrodt to acquire CNS Therapeutics
Medical device maker Covidien LLC’s pharmaceutical arm, Mallinckrodt, has entered into a definitive agreement to acquire St. Paul, Minn.-based CNS Therapeutics Inc. more
| 9/24/12
Covidien lands added FDA approval for LigaSure
Covidien PLC has received 510(k) clearance from the U.S. Food and Drug Administration to use its LigaSure curved, small jaw, open sealer/divider in ear, nose and throat procedures. more
| 9/11/12
ProThera Biologics lands $750K from Slater, NIH
East Providence biomedical company ProThera Biologics LLC - led by Rhode Island Hospital scientists Dr. Yow-Pin Lim, above, and Douglas Hixson - has received $750,000 in new funding from the National Institutes of Health and Slater Technology Fund. more
« Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 Next »
Calendar
PBN Hosted
Events

Celebrate RI's many exceptional women at PBN's Business Women Awards luncheon May 30th at the Providence Marriott. Reserve your seat today!
Advertisement
National
Local
Latest News